complaint·May 10, 2023

Staff reported that when R1 arrived at the facility they received medication from the SNF and continued to administer the medication until it was refilled on 4/27/23. Witnesses interviewed reported that medication for R1 was delivered to the facility by a family member on 5/1/23. Witnesses interviewed reported that R1 did not receive any medication from 4/22/23 until 5/1/23 except for Levothyroxine Sodium 137 MCG tablets. Witnesses and staff report conflicting information concerning the administration of R1’s medication. LPA conducted an audit of R1’s medication for May 2023 with staff present, which included a review of the MAR for May 2023, no discrepancies were observed. A review of the MAR for April 2023 for R1 shows that R1 received 7 medications daily from 4/27/23 to 4/29/23 and no medications administered from 4/22/23 to 4/26/23 and 4/30/2 3. Staff reported that the medications from the SNF were administered but not listed on the MAR for April 2023. Based on the evidence gathered through interviews and a review of records the preponderance of evidence standard has been met, therefore the allegation, facility is mismanaging resident's medication is found to be Substantiated. Violations are being cited per California Code of Regulations Title 22, Division 6, Chapter 8. An exit interview was conducted and a copy of this report along with citation and Appeal Rights (LC 9058 3/22) was provided.